Health-Related Quality of Life in Lenalidomide and Bortezomib Treated Patients with Relapsed/Refractory Multiple Myeloma

被引：0
|
作者：
Kyriakou, Charalampia [1 ,2 ]
Murphy, Philip [3 ]
Petrucci, Maria Teresa [4 ]
Bacon, Pamela [5 ]
Lewis, Philip [6 ]
Gilet, Helene [7 ]
Arnould, Benoit [7 ]
Vande Broek, Isabelle [8 ]
Leleu, Xavier [9 ]
机构：
[1] Royal Free Hosp, Dept Haematol, London NW3 2QG, England
[2] Northwick Pk Hosp & Clin Res Ctr, Dept Haematol, London NW3 2QG, England
[3] Beaumont Hosp, Dublin 9, Ireland
[4] Univ Roma La Sapienza, Div Hematol, Dept Cellular Biotechnol & Hematol, I-00185 Rome, Italy
[5] Celgene Int Sarl, Boudry, Switzerland
[6] Celgene GmbH, Munich, Germany
[7] Mapi, Lyon, France
[8] Iridium Kankernetwerk, St Niklaas, Belgium
[9] Hop Claude Huriez, CHRU, Lille, France
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] BORTEZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN THE MANAGEMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA: A REAL-LIFE EXPERIENCE
    Cerchione, C.
    Zacheo, I.
    Di Perna, M.
    Nappi, D.
    Pareto, A. E.
    Peluso, I.
    Ferrara, K.
    Pane, F.
    Catalano, L.
    [J]. HAEMATOLOGICA, 2017, 102 : 140 - 140
  • [22] POMALIDOMIDE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) PREVIOUSLY TREATED WITH LENALIDOMIDE
    Gomez, Hernando Marta
    Gironella, Merce
    Abella, Eugenia
    Cabezudo, Elena
    Motllo, Cristina
    Garcia, Antoni
    Sarra, Josep
    Mostacedo, Silvia
    Granell, Miquel
    Rosinol, Laura
    [J]. HAEMATOLOGICA, 2020, 105 : 13 - 14
  • [23] Physical Function, Pain Severity, and Fatigue in Patients with Relapsed/Refractory Multiple Myeloma: Health-Related Quality of Life Results in Patients Receiving Venetoclax or Placebo in Combination with Bortezomib and Dexamethasone
    Gasparetto, Cristina
    Popat, Rakesh
    Kumar, Shaji K.
    Cavo, Michele
    de la Rubia, Javier
    Hungria, Vania T. M.
    Salwender, Hans
    Suzuki, Kenshi
    Kim, Inho
    Maciel, James
    Hsiao, Liang-Tsai
    Moreau, Philippe
    Harrison, Simon
    Jia, Jia
    Karve, Sudeep
    Ma, Esprit
    Devine, Jacob
    Benjamin, Katy
    [J]. BLOOD, 2019, 134
  • [24] Health-related quality of life in relapsed/refractory multiple myeloma treated with melflufen and dexamethasone: analyses from the phase III OCEAN study
    Schjesvold, Fredrik H.
    Ludwig, Heinz
    Delimpasi, Sossana
    Robak, Pawel
    Coriu, Daniel
    Tomczak, Waldemar
    Pour, Ludek
    Spicka, Ivan
    Dimopoulos, Meletios-Athanasios
    Masszi, Tamas
    Chernova, Natalia G.
    Sandberg, Anna
    Thuresson, Marcus
    Norin, Stefan
    Bakker, Nicolaas A.
    Mateos, Maria-Victoria
    Richardson, Paul G.
    Sonneveld, Pieter
    [J]. REVISTA CHILENA DE LITERATURA, 2024, (109): : 2331 - 2336
  • [25] Health-related quality of life in relapsed/refractory multiple myeloma treated with melflufen and dexamethasone: analyses from the phase III OCEAN study
    Schjesvold, Fredrik H.
    Ludwig, Heinz
    Delimpasi, Sossana
    Robak, Pawel
    Coriu, Daniel
    Tomczak, Waldemar
    Pour, Ludek
    Spicka, Ivan
    Dimopoulos, Meletios-Athanasios
    Masszi, Tamas
    Chernova, Natalia G.
    Sandberg, Anna
    Thuresson, Marcus
    Norin, Stefan
    Bakker, Nicolaas A.
    Mateos, Maria-Victoria
    Richardson, Paul G.
    Sonneveld, Pieter
    [J]. HAEMATOLOGICA, 2024, 109 (07) : 2331 - 2336
  • [26] The Accuracy of the International Myeloma Working Group Frailty Score in Capturing Health-Related Quality of Life Profile of Patients with Relapsed Refractory Multiple Myeloma
    Efficace, Fabio
    Gaidano, Gianluca
    Petrucci, Maria Teresa
    Niscola, Pasquale
    Tognazzi, Lucia
    Antonioli, Elisabetta
    Cottone, Francesco
    Annibali, Ombretta
    Tafuri, Agostino
    Califano, Catello
    Larocca, Alessandra
    Potenza, Leonardo
    Palazzo, Giulia
    Fozza, Claudio
    Pastore, Domenico
    Rigolin, Gian Matteo
    Offidani, Massimo
    Romano, Alessandra
    Tosi, Patrizia
    Kyriakou, Charalampia
    Cascavilla, Nicola
    Molica, Stefano
    Gozzetti, Alessandro
    Derudas, Daniele
    Vignetti, Marco
    Cavo, Michele
    [J]. BLOOD, 2021, 138
  • [27] LENALIDOMIDE THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Okada, K.
    Okamoto, Y.
    Tsukamoto, T.
    Sugiura, H.
    Matsui, H.
    Ueda, T.
    Jo, T.
    Onishi, T.
    Kunitomi, A.
    Ueda, Y.
    [J]. ANNALS OF ONCOLOGY, 2013, 24
  • [28] Patient perspectives on symptoms, health-related quality of life, and treatment experience associated with relapsed/refractory multiple myeloma
    Nitya Nathwani
    Jill Bell
    Dasha Cherepanov
    France Ginchereau Sowell
    Rachel Shah
    Kelly McCarrier
    Parameswaran Hari
    [J]. Supportive Care in Cancer, 2022, 30 : 5859 - 5869
  • [29] Patient perspectives on symptoms, health-related quality of life, and treatment experience associated with relapsed/refractory multiple myeloma
    Nathwani, Nitya
    Bell, Jill
    Cherepanov, Dasha
    Sowell, France Ginchereau
    Shah, Rachel
    McCarrier, Kelly
    Hari, Parameswaran
    [J]. SUPPORTIVE CARE IN CANCER, 2022, 30 (07) : 5859 - 5869
  • [30] Health-Related Quality of Life in the Cartitude-1 Study of Ciltacabtagene Autoleucel for Relapsed/Refractory Multiple Myeloma
    Martin, Thomas, III
    Lin, Yi
    Agha, Mounzer
    Cohen, Adam D.
    Htut, Myo
    Stewart, A. Keith
    Hari, Parameswaran
    Berdeja, Jesus G.
    Madduri, Deepu
    Usmani, Saad Z.
    Yeh, Tzu-Min
    Allred, Alicia J.
    Olyslager, Yunsi
    Banerjee, Arnob
    Goldberg, Jenna D.
    Schecter, Jordan M.
    Jackson, Carolyn C.
    Deraedt, William
    Gries, Katharine S.
    Fastenau, John
    Wu, Xiaoling
    Carrasco, Marlene J.
    Akram, Muhammad
    Hossain, Farah
    Jakubowiak, Andrzej
    Jagannath, Sundar
    [J]. BLOOD, 2020, 136
12345